These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 4305316)

  • 21. [Renal function in cirrhotic patients. II. Tubular reabsorption of sodium and diuresis].
    Solís Herruzo JA; Pardo Rueda J
    Rev Clin Esp; 1971 Jul; 122(2):99-110. PubMed ID: 5164616
    [No Abstract]   [Full Text] [Related]  

  • 22. [The renin-angiotensin-aldosterone system during the extraction, concentration and reinfusion of ascitic fluid in cirrhotic patients].
    Giorcelli V; Fossale PG
    Arch Sci Med (Torino); 1983; 140(3):273-80. PubMed ID: 6675585
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Amiloride. A clinical study of a potassium-retaining diuretic].
    Juul J
    Ugeskr Laeger; 1969 Oct; 131(42):1785-90. PubMed ID: 4914022
    [No Abstract]   [Full Text] [Related]  

  • 24. Angiotensin-aldosterone interrelationship in liver cirrhosis.
    Higazi AM; Khalifa K; el-Ebrashy N; Abdel Hamid H; Safourie S
    J Egypt Med Assoc; 1967; 50(1):1-13. PubMed ID: 4294597
    [No Abstract]   [Full Text] [Related]  

  • 25. [On the maintenance of proper osmolality and volume of body fluids. 3. The diuretic effect of intravenous and intragastric saline infusions in the human].
    Lydtin H
    Z Gesamte Exp Med Einschl Exp Chir; 1969; 149(3):211-25. PubMed ID: 5780354
    [No Abstract]   [Full Text] [Related]  

  • 26. Angiotensin-induced natriuresis in cirrhosis in the absence of endogenous aldosterone secretion.
    McCloy RM; Baldus WP; Summerskill WH; Maher FT
    Ann Intern Med; 1966 Jun; 64(6):1271-6. PubMed ID: 4286738
    [No Abstract]   [Full Text] [Related]  

  • 27. Reversal of atrial natriuretic peptide resistance by increasing distal tubular sodium delivery in patients with decompensated cirrhosis.
    Abraham WT; Lauwaars ME; Kim JK; Peña RL; Schrier RW
    Hepatology; 1995 Sep; 22(3):737-43. PubMed ID: 7657277
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of dipyridamole on kidney function in cirrhosis.
    Llach J; Ginès P; Arroyo V; Salmerón JM; Ginès A; Jiménez W; Gaya J; Rivera F; Rodés J
    Hepatology; 1993 Jan; 17(1):59-64. PubMed ID: 8423042
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Effect differences between angiotensin II and noradrenalin in reference to diuresis, sodium and potassium excretion in healthy persons and patients with kidney diseases].
    Pogglitsch H; Giessauf W; Stöckl G; Feldner H; Kratochvil K
    Wien Z Inn Med; 1970; 51(7):324-9. PubMed ID: 4331448
    [No Abstract]   [Full Text] [Related]  

  • 30. [Contribution to the study of the interference of the renin-angiotensin-aldosterone system during the development of chronic alcoholic hepatopathy].
    Bourel M; Pirot D; Lenoir P; Chauvel A; Pawlotsky Y; Simon M
    Rev Int Hepatol; 1968; 18(7):871-94. PubMed ID: 4307168
    [No Abstract]   [Full Text] [Related]  

  • 31. Failure of the cirrhotic liver to inactivate renin: evidence for a splanchnic source of renin-like activity.
    Barnardo DE; Strong CG; Baldus WP
    J Lab Clin Med; 1969 Sep; 74(3):495-506. PubMed ID: 4308911
    [No Abstract]   [Full Text] [Related]  

  • 32. Nitric oxide synthase inhibition does not improve renal function in cirrhotic patients with ascites.
    Thiesson HC; Skøtt O; Jespersen B; Schaffalitzky de Muckadell OB
    Am J Gastroenterol; 2003 Jan; 98(1):180-6. PubMed ID: 12526955
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Systemic infusion of angiotensin II exacerbates liver fibrosis in bile duct-ligated rats.
    Bataller R; Gäbele E; Parsons CJ; Morris T; Yang L; Schoonhoven R; Brenner DA; Rippe RA
    Hepatology; 2005 May; 41(5):1046-55. PubMed ID: 15841463
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vasoactive factors in decompensated cirrhosis. Effect of acute plasma expansion.
    La Villa G; Laffi G; Pinzani M; Pampana A; Mannelli M; Smorlesi C; Gentilini P
    Boll Soc Ital Biol Sper; 1984 Mar; 60(3):535-41. PubMed ID: 6561965
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Simultaneous, study of systemic and regional visceral hemodynamics in cirrhosis. 3. Systemic and hepatosplanchnic hemodynamics in decompensated liver cirrhosis, with ascites].
    Greco F; Chiandussi L; Sardi G; Vaccarino A; Curti B; Agostoni A; Zardini P; Toscano G
    Minerva Med; 1967 Feb; 58(11):364-7. PubMed ID: 6019271
    [No Abstract]   [Full Text] [Related]  

  • 36. [Effect of low-dose angiotensin II on urinary function in waking adrenalectomized dogs].
    Ader JL; Geral JP
    C R Seances Soc Biol Fil; 1973; 167(3):541-3. PubMed ID: 4361799
    [No Abstract]   [Full Text] [Related]  

  • 37. [Influence of Na supplement and limitation on blood PRA, AII, ALD and renal function in patients with liver cirrhosis].
    Gu XB; Chen HK; Zhu YF; Pei H; Liu XY
    Zhonghua Gan Zang Bing Za Zhi; 2004 Jun; 12(6):370. PubMed ID: 15225438
    [No Abstract]   [Full Text] [Related]  

  • 38. Hepatic hemodynamics and the renin-angiotensin-aldosterone system in cirrhosis.
    Bosch J; Arroyo V; Betriu A; Mas A; Carrilho F; Rivera F; Navarro-Lopez F; Rodes J
    Gastroenterology; 1980 Jan; 78(1):92-9. PubMed ID: 7350041
    [No Abstract]   [Full Text] [Related]  

  • 39. [Mercamine effects on the diuresis and survival of rats poisoned by corrosive mercuric chloride].
    Chernenko GT
    Farmakol Toksikol; 1965; 28(3):355-7. PubMed ID: 5869658
    [No Abstract]   [Full Text] [Related]  

  • 40. [Suppression by spirolactones of the natriuretic effect of angiotensin peculiar to certain cirrhotics].
    Stahl J; Jahn H; Réville P; Kurtz T; Kuntzmann F
    C R Acad Hebd Seances Acad Sci D; 1965 Dec; 261(23):5247-9. PubMed ID: 4285131
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.